JB Chemicals rises on acquiring brand 'Azmarda' from Novartis

13 Apr 2022 Evaluate

JB Chemicals is currently trading at Rs. 1610.35, up by 5.85 points or 0.36% from its previous closing of Rs. 1604.50 on the BSE.

The scrip opened at Rs. 1613.60 and has touched a high and low of Rs. 1615.25 and Rs. 1604.45 respectively. So far 403 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1984.75 on 28-Sep-2021 and a 52 week low of Rs. 1206.35 on 16-Apr-2021.

Last one week high and low of the scrip stood at Rs. 1690.00 and Rs. 1591.40 respectively. The current market cap of the company is Rs. 12418.07 crore.

The promoters holding in the company stood at 54.00%, while Institutions and Non-Institutions held 25.38% and 20.62% respectively.

JB Chemicals & Pharmaceuticals has successfully completed the acquisition of the brand 'Azmarda' from Novartis AG, Switzerland. Azmarda indicated for heart failure patients with reduced ejection fraction (HfrEF).

JB Chemicals & Pharmaceuticals is engaged in manufacturing of pharmaceutical specialties in various dosage forms, herbal remedies, diagnostics, generic drugs, active pharmaceutical ingredients (APIs).

JB Chem & Pharma Share Price

1950.00 71.20 (3.79%)
31-Oct-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1849.05
Dr. Reddys Lab 1274.25
Cipla 1553.20
Lupin 2184.00
Zydus Lifesciences 1001.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.